Pre-Sale Business Due Diligence
Audit your company through a buyer’s eyes before weaknesses reduce its value
- Difficulty
- Advanced
- Time to result
- ~months to results
- Steps
- 6
- Confidence
- 97%
Instead of waiting for an acquisition process to expose a company’s weaknesses, this method applies buyer-grade due diligence while the founder still has time to make improvements. The audit examines the whole business rather than relying only on revenue or profit: systems, recurring revenue, margins, offers, team quality, leadership, market risks, and growth opportunities all influence value. Each weakness is viewed as a point a buyer could use to devalue the company or negotiate less favorable terms. The output is a prioritized forward strategy, typically spanning two to three years, that strengthens profitability, reduces owner dependency, removes operational risk, and preserves the founder’s freedom to sell or retain the company.
Origin
Jessica Marx developed this approach after participating in a multibillion-dollar acquisition and seeing that conventional due diligence often exposes problems only when a company is already trying to sell.
Core principles
- 01Treat the business as an asset, not merely a source of income
- 02Expose weaknesses before a buyer discovers them
- 03Evaluate value drivers beyond the profit-and-loss statement
- 04Turn every material risk into a prioritized improvement plan
- 05Build for optionality even when no immediate sale is planned
How to run it
- 1
Define the Desired Outcome
Clarify whether the company is being built for an eventual sale, long-term cash flow, or both. Use that destination to determine which value drivers matter most.
Pro tip Preserve optionality by building a sellable company even if the founder currently intends to keep it.
Watch out An undefined destination can produce conflicting investment and profitability decisions.
- 2
Audit the Entire Business
Review financial performance, margins, recurring revenue, offers, systems, operations, team structure, leadership capability, and owner dependency. Gather evidence rather than relying on the founder’s impressions.
Pro tip Include historical metrics and market context so current performance is interpreted accurately.
Watch out A profit-and-loss statement alone cannot reveal whether a company is scalable or transferable.
- 3
Adopt the Buyer’s Lens
Identify every weakness that would concern a buyer or create negotiating leverage. Estimate how each issue affects risk, transferability, and valuation.
Pro tip Ask what would make you reduce your own offer if you were investing personal money.
Watch out Emotional attachment can cause founders to minimize risks that are obvious to outsiders.
- 4
Map Risks and Opportunities
Evaluate external market threats alongside internal growth opportunities. Distinguish urgent structural risks from attractive but lower-priority expansion ideas.
Pro tip Rank issues by their effect on enterprise value, not by how visible or interesting they feel.
Watch out Working on an appealing downstream opportunity before fixing a foundational weakness can waste capital.
- 5
Write the Forward Strategy
Convert findings into a sequenced two-to-three-year plan with measurable priorities. Assign owners, targets, and review points to each initiative.
Pro tip Connect every initiative to profitability, scalability, risk reduction, or valuation.
Watch out An unsequenced list of recommendations encourages teams to pursue too many changes at once.
- 6
Reassess Regularly
Repeat the buyer-lens review as the business, team, and market evolve. Confirm that completed changes have genuinely reduced risk and improved performance.
Pro tip Use consistent metrics so progress can be compared across reviews.
Watch out A one-time audit becomes obsolete as new offers, hires, and market conditions emerge.
In the wild
A profitable course-and-membership company appears successful but depends on its founder for sales, content, and delivery. A buyer-lens audit reveals weak recurring revenue retention, undocumented operating systems, and no qualified second-in-command. The founder prioritizes retention, documents delivery, and develops independent leadership over the next two years.
→ The company becomes less owner-dependent, generates more reliable cash flow, and presents fewer reasons for a buyer to reduce its valuation.
A $3 million service firm believes marketing is its growth blocker. Full due diligence shows that low-margin offers and an underqualified leadership layer are the deeper constraints. The firm restructures its offer suite before increasing marketing expenditure and then hires leadership suited to its next stage.
→ Margins improve, marketing becomes economically viable, and growth no longer increases the founder’s workload at the same rate.
Common mistakes
Waiting Until the Sale Process
Discovering weaknesses after buyers and advisers become involved leaves little time to correct them and gives the buyer greater negotiating leverage.
Treating Revenue as Enterprise Value
High revenue does not compensate for poor margins, fragile systems, weak leadership, or dependence on the founder.
Fixing the Self-Diagnosed Symptom
Founders frequently identify sales, marketing, or branding as the problem when a more fundamental issue sits several steps earlier in the business model.
Is it for you?
Best for
It is best for established founder-led businesses that want greater profitability, scalability, or the option of a future exit.
Not ideal for
It is not ideal for very early businesses that have not yet validated an offer or established meaningful operating data.
From the transcript
“Prior to me starting this firm, the only time a company went through due diligence is when they were ready to sell.”
“It's more than the PNL. It doesn't have the right systems. It doesn't have the right reoccurring revenue. It doesn't have the right margins, it…”
“Here's all of the areas where if I was coming in with my own dollars to buy you, I would devalue you or I would…”
From the episode
How to Build a Sellable Business That Doesn’t Depend on You with Jessica Marx
Jessica Marx